Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Martel · SciRah

Researcher profile · Semantic Scholar

S. Martel

Share profile

S. Martel — researcher profile on SciRah

h-index: 11
Works: 40
Citations: 400

Most-cited papers

Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2–positive early breast cancer: Analysis from the NeoALTTO (BIG 1‐06) and ALTTO (BIG 2‐06) trials
M. Lambertini, S. Martel, C. Campbell, S. Guillaume +13 more
2018Cancer67 citations Open access
Semantic Scholar
Breast cancer treatment-induced cardiotoxicity
S. Martel, C. Maurer, M. Lambertini, N. Pondé +1 more
2017Expert Opinion on Drug Safety66 citations
Semantic Scholar
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis
F. Poggio, M. Bruzzone, M. Ceppi, B. Conte +7 more
2018ESMO Open60 citations Open access
Semantic Scholar
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer.
S. Martel, E. Poletto, A. Ferreira, M. Lambertini +12 more
2018Breast39 citations Open access
Semantic Scholar
Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis
M. Brandão, C. Maurer, P. K. Ziegelmann, N. Pondé +6 more
2020ESMO Open32 citations Open access
Semantic Scholar
Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial.
S. Martel, M. Lambertini, D. Agbor-tarh, N. Pondé +12 more
2021The Journal of the National Comprehensive Cancer Network25 citations Open access
Semantic Scholar
Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis.
S. Martel, M. Bruzzone, M. Ceppi, C. Maurer +7 more
2018Cancer Treatment Reviews21 citations Open access
Semantic Scholar
New agents for endocrine resistance in breast cancer.
C. Maurer, S. Martel, D. Zardavas, M. Ignatiadis
2017Breast18 citations Open access
Semantic Scholar
Paraneoplastic neurologic syndromes: clinical presentation and management.
S. Martel, Flávia De Angelis, E. Lapointe, S. Larue +1 more
2014Current Problems in Cancer16 citations
Semantic Scholar
Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer.
C. Maurer, A. Ferreira, S. Martel, M. Lambertini +4 more
2018Breast13 citations Open access
Semantic Scholar
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
E. Agostinetto, L. Ameye, S. Martel, P. Aftimos +16 more
2022npj Breast Cancer12 citations Open access
Semantic Scholar
Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial
C. Maurer, E. Agostinetto, L. Ameye, M. Lambertini +12 more
2025Breast Cancer Research and Treatment6 citations Open access
Semantic Scholar
Body mass index and weight changes in patients with HER2-positive early breast cancer: A sub-analysis of the APHINITY trial.
C. Dauccia, Maria Alice Franzoi, S. Martel, D. Agbor-tarh +16 more
2025European Journal of Cancer6 citations Open access
Semantic Scholar
PARP inhibitors (PARPi) for the treatment of BRCA-mutated HER2-negative (HER2-) metastatic breast cancer (MBC) patients: A systematic review and meta-analysis.
F. Poggio, M. Bruzzone, M. Ceppi, B. Conte +7 more
20183 citations
Semantic Scholar
Male breast cancer: finding the way in this uncommon path
C. Maurer, S. Martel, E. de Azambuja
2017ESMO Open3 citations Open access
Semantic Scholar
[Severe suicides: short- and long-term outcome. Assessment of their quality of life].
M. Gaillard, S. Martel, P. Reynaud, L. Mercadal +2 more
1990Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression3 citations
Semantic Scholar
Serious suicides. Short and long-term results. One hundred and fifty six cases with a follow-up period of 1 to 7 years.
C. Hervé, M. Gaillard, S. Martel, P. Huguenard
1984Acta anaesthesiologica Belgica3 citations
Semantic Scholar
Impact of body mass index (BMI) and weight change after treatment in patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Secondary analysis of the ALTTO BIG 2-06 trial.
S. Martel, M. Lambertini, D. Agbor-tarh, N. Pondé +12 more
20182 citations
Semantic Scholar
Adherence to guidelines in requesting Oncotype DX in a publicly funded health care system.
S. Martel, M. Lambertini, Renée Simon, C. Matte +1 more
2018Current Oncology2 citations Open access
Semantic Scholar
Concordance between liquid and tissue biopsy in participants with newly diagnosed recurrent breast cancer.
A. Lohmann, M. Ennis, P. Goodwin, Z. Veitch +13 more
2023Journal of Clinical Oncology1 citations
Semantic Scholar
The prognostic performance of PREDICT+ in patients (pts) with HER2-positive (HER2+) early-stage breast cancer (EBC).
E. Agostinetto, L. Ameye, S. Martel, P. Aftimos +16 more
20211 citations
Semantic Scholar
Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trial.
A. Ferreira, S. Ferreira, M. Lambertini, C. Maurer +4 more
2020European Journal of Cancer1 citations Open access
Semantic Scholar
Neoadjuvant biomarker research study of palbociclib combined with endocrine therapy in estrogen receptor positive/HER2 negative breast cancer: The phase II NeoRHEA trial.
M. Ignatiadis, M. Brandão, M. Maetens, N. Pondé +14 more
2018Annals of Oncology1 citations Open access
Semantic Scholar
Concordance between circulating tumor DNA and tissue biopsy in patients with newly diagnosed recurrent breast cancer.
A. Lohmann, M. Ennis, Z. Veitch, C. Brezden-Masley +11 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
69P Impact of statin use on survival outcomes of patients with HER2-positive early breast cancer in the APHINITY trial
C. Maurer, E. Agostinetto, L. Ameye, M. Lambertini +12 more
2022Annals of Oncology0 citations Open access
Semantic Scholar
Authors' Reply To the Letters to the Editor by Puklin et al and by Iyengar and Ligibel.
S. Martel, M. Lambertini, E. de Azambuja
2022The Journal of the National Comprehensive Cancer Network0 citations Open access
Semantic Scholar
131P Impact of body mass (BMI) and weight change after adjuvant treatment in patients (pts) with HER2-positive early breast cancer
M. Franzoi, S. Martel, D. Agbor-tarh, M. Piccart +13 more
2021Annals of Oncology0 citations Open access
Semantic Scholar
Abstract P4-10-09: Association between pertuzumab (P) induced diarrhea and skin rash and survival outcomes in patients (pts) with HER2-positive metastatic breast cancer enrolled in the CLEOPATRA trial
A. Ferreira, N. Pondé, M. Lambertini, C. Maurer +3 more
2020Poster Session Abstracts0 citations
Semantic Scholar
49P BRCA mutation testing rates among breast cancer patients meeting testing criteria: A single-centre experience
M. Boianu, N. Daaboul, G. Speranza, C. Prady +2 more
20200 citations Open access
Semantic Scholar
Retrospective study of neuroendocrine breast cancer cases from a single institution in Québec.
M. Plante, Paul-Michel Houle, C. Prady, S. Martel +2 more
2019Journal of Clinical Oncology0 citations
Semantic Scholar
Clinical outcomes of patients (pts) with Human Epidermal Growth Factor Receptor 2 (HER2) equivocal early breast cancer (EBC)
A. Desnoyers, D. Berbiche, F. Fortin, M. Dami +5 more
2019Breast0 citations
Semantic Scholar
Abstract P4-13-01: Endocrine treatment for hormone receptor-positive advanced breast cancer patients with endocrine-sensitive or endocrine-resistant disease: A systematic review and network meta-analysis
M. Brandão, C. Maurer, P. Ziegelmann, N. Pondé +6 more
2019Poster Session Abstracts0 citations
Semantic Scholar
Pregnancies during and following trastuzumab (T) and/or lapatinib (L) in patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.
M. Lambertini, S. Martel, C. Campbell, S. Guillaume +13 more
20180 citations
Semantic Scholar
Reply to the letter "Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients: An alternative explanation for the lack of association".
E. Poletto, S. Martel, M. Lambertini, F. Puglisi
2018Breast0 citations
Semantic Scholar
Breast cancer and pregnancy-related issues
Matteo Lambertini, B. Nguyen, G. Viglietti, S. Martel +1 more
20180 citations
Semantic Scholar
PO75 RETROSPECTIVE ANALYSIS OF ADVANCED LUMINAL BREAST CANCER PATIENTS TREATED WITH ENDOCRINE THERAPY (ET) ANDPALBOCICLIBWITHINACOMPASSIONATE USE PROGRAMME
C. Maurer, P. Aftimos, E. de Azambuja, S. Martel +31 more
20170 citations
Semantic Scholar
Retrospective Analysis of Advanced Luminal Breast Cancer Patients Treated with Endocrine Therapy (ET) and Palbociclib Within a Compassionate Use Programme
C. Maurer, P. Aftimos, E. de Azambuja, S. Martel +4 more
20170 citations
Semantic Scholar
Adverse Events (AE) of Targeted Agents Added to Endocrine Therapy in Patients with Hormone Receptor-positive Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
M. Lambertini, M. Bruzzone, M. Ceppi, C. Maurer +7 more
20170 citations
Semantic Scholar
Abstract P2-05-30: OncotypeDX® for breast cancer: A multigene assay that makes a difference?
S. Martel, C. Prady, Renée Simon, C. Matte
20170 citations
Semantic Scholar
289PThe CAN BEAR study: A systematic review and meta-analysis investigating adverse events (AEs) of targeted agents added to endocrine therapy (ET) in patients (pts) with hormone-receptor positive (HR+) metastatic breast cancer (MBC)
S. Martel, M. Bruzzone, M. Ceppi, C. Maurer +7 more
20170 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. de Azambuja×26
Invite
E. de Azambuja — researcher profile on SciRah
C. Maurer×21
Invite
C. Maurer — researcher profile on SciRah
M. Lambertini×17
Invite
M. Lambertini — researcher profile on SciRah
N. Pondé×17
Invite
N. Pondé — researcher profile on SciRah

×13

Invite

A. Ferreira — researcher profile on SciRah

L. Del Mastro×10

Invite

L. Del Mastro — researcher profile on SciRah

Invite

M. Piccart — researcher profile on SciRah

M. Lambertini×8

Invite

M. Lambertini — researcher profile on SciRah

Invite

C. Prady — researcher profile on SciRah

S. Di Cosimo×6

Invite

S. Di Cosimo — researcher profile on SciRah

A. Moreno-Aspitia×6

Invite

A. Moreno-Aspitia — researcher profile on SciRah

G. Viglietti×6

Invite

G. Viglietti — researcher profile on SciRah